The Centers for Medicare and Medicaid Services (CMS) recently released S&C Memo 13-35-NH, which discusses the use of psychopharmacological medications and behavioral management in America’s Nursing Homes. The management of behavioral or psychological symptoms of dementia (BPSD) is a challenge in Nursing Homes. In this presentation viewers will learn valuable behavioral management techniques that can be utilized to decrease patient dependency on psychopharmacological medication. Important government initiatives, including The Partnership to Improve Dementia Care in Nursing Homes are discussed. The presentation also discusses the recent updates to interpretive guidelines of F309 (Quality of Care) and F329 (Unnecessary Drugs), and details the Seven Dementia Care Principles provided by CMS to assist nursing homes to manage behavioral or psychological symptoms of BPSD.
1. Learn the content of S&C Memo 13-35-NH and the implications of this memo on daily resident care
2. Learn to articulate the intent and impact of F309 and F329 on resident health and well-being, and identify strategies to maintain compliance with the regulatory intent of these regulations
3. Learn about the seven Dementia Care Principles provided by CMS to assist nursing homes to manage behavioral or psychological symptoms of BPSD
4. Identify the seven Dementia Care Principles provided by CMS to assist nursing homes to manage behavioral or psychological symptoms of BPSD
Pharmacological guidelines in the treatment of schizophreniaehab elbaz
This document provides pharmacological guidelines for treating schizophrenia. It discusses the different phases of treatment including prodrome, first episode, maintenance, and relapse. It offers recommendations on choosing medications, managing side effects, preventing relapse, and treating treatment-resistant cases. Electroconvulsive therapy may be an option for patients who do not respond to pharmacological interventions alone. The guidelines are meant to help develop an evidence-based approach to prescription while minimizing improper prescribing.
This document provides information on psychoactive drugs used to treat psychiatric conditions. It defines psychoactive drugs as substances that act on the central nervous system, altering brain function and resulting in changes in perception, mood, consciousness, and behavior. The document then summarizes several classes of psychoactive drugs - antipsychotics, antidepressants, mood stabilizers, anxiolytics, stimulants, and depressants - listing their indications, mechanisms of action, side effects, and nursing responsibilities for each.
This document discusses psychopharmacology and summarizes various types of psychotropic medications. It identifies 9 classes of drugs including antipsychotics, antimanic drugs, antidepressants, antianxiety medications, stimulants, narcotic analgesics, hypnotics, and addiction treatment medications. It also outlines common side effects, risks, and cautions for these drug classes and lists strategies for helping clients with tobacco cessation.
This document provides an overview of addiction psychiatry including:
- The neurobiology of addiction and how chronic drug use decreases dopamine levels and impacts brain regions responsible for motivation, inhibition and determining importance.
- Dually diagnosed patients often have substance use disorders and psychiatric illnesses which complicate treatment. Integrated treatment is recommended.
- Motivational interviewing and relapse prevention therapy aim to help patients through the stages of change to maintain sobriety.
- Pharmacological interventions for various addictions including opioids, alcohol and cocaine are discussed though more research is still needed on effective medications.
- A case example involves assessing potential prescription opioid misuse or addiction in a chronic pain patient.
Antipsychotic medications are used to treat various psychotic disorders like schizophrenia. Typical antipsychotics work by blocking dopamine D2 receptors, while atypical antipsychotics have diverse receptor profiles. Both types can cause extrapyramidal side effects, but atypicals have a lower risk. Selection of an antipsychotic requires weighing efficacy, side effect profile, medical comorbidities, and other individual factors. Treatment aims to reduce symptoms, improve long-term outcomes, and prevent relapse.
This document discusses pediatric psychopharmacology and provides evidence for the effectiveness of psychotropic medications in treating several childhood disorders including ADHD, bipolar disorder, depression, OCD, and schizophrenia. It outlines the history and regulations around studying these drugs in children. While some oppose medicating children due to unknown long-term effects, evaluations are required and studies show medications can significantly improve symptoms and functioning for conditions that cannot be managed by behavioral interventions alone. Common drug classes and specific medications are described for each disorder.
Psychotherapeutic agents are a key component in the management of psychiatric disorders. Knowledge in this aspect of therapy goes a long way to help the health professional and the patient as well. However, care must be taken in administering these agents to pregnant women, and if possible stop, or consult your psychiatrist before taking these agents.
Pharmacological guidelines in the treatment of schizophreniaehab elbaz
This document provides pharmacological guidelines for treating schizophrenia. It discusses the different phases of treatment including prodrome, first episode, maintenance, and relapse. It offers recommendations on choosing medications, managing side effects, preventing relapse, and treating treatment-resistant cases. Electroconvulsive therapy may be an option for patients who do not respond to pharmacological interventions alone. The guidelines are meant to help develop an evidence-based approach to prescription while minimizing improper prescribing.
This document provides information on psychoactive drugs used to treat psychiatric conditions. It defines psychoactive drugs as substances that act on the central nervous system, altering brain function and resulting in changes in perception, mood, consciousness, and behavior. The document then summarizes several classes of psychoactive drugs - antipsychotics, antidepressants, mood stabilizers, anxiolytics, stimulants, and depressants - listing their indications, mechanisms of action, side effects, and nursing responsibilities for each.
This document discusses psychopharmacology and summarizes various types of psychotropic medications. It identifies 9 classes of drugs including antipsychotics, antimanic drugs, antidepressants, antianxiety medications, stimulants, narcotic analgesics, hypnotics, and addiction treatment medications. It also outlines common side effects, risks, and cautions for these drug classes and lists strategies for helping clients with tobacco cessation.
This document provides an overview of addiction psychiatry including:
- The neurobiology of addiction and how chronic drug use decreases dopamine levels and impacts brain regions responsible for motivation, inhibition and determining importance.
- Dually diagnosed patients often have substance use disorders and psychiatric illnesses which complicate treatment. Integrated treatment is recommended.
- Motivational interviewing and relapse prevention therapy aim to help patients through the stages of change to maintain sobriety.
- Pharmacological interventions for various addictions including opioids, alcohol and cocaine are discussed though more research is still needed on effective medications.
- A case example involves assessing potential prescription opioid misuse or addiction in a chronic pain patient.
Antipsychotic medications are used to treat various psychotic disorders like schizophrenia. Typical antipsychotics work by blocking dopamine D2 receptors, while atypical antipsychotics have diverse receptor profiles. Both types can cause extrapyramidal side effects, but atypicals have a lower risk. Selection of an antipsychotic requires weighing efficacy, side effect profile, medical comorbidities, and other individual factors. Treatment aims to reduce symptoms, improve long-term outcomes, and prevent relapse.
This document discusses pediatric psychopharmacology and provides evidence for the effectiveness of psychotropic medications in treating several childhood disorders including ADHD, bipolar disorder, depression, OCD, and schizophrenia. It outlines the history and regulations around studying these drugs in children. While some oppose medicating children due to unknown long-term effects, evaluations are required and studies show medications can significantly improve symptoms and functioning for conditions that cannot be managed by behavioral interventions alone. Common drug classes and specific medications are described for each disorder.
Psychotherapeutic agents are a key component in the management of psychiatric disorders. Knowledge in this aspect of therapy goes a long way to help the health professional and the patient as well. However, care must be taken in administering these agents to pregnant women, and if possible stop, or consult your psychiatrist before taking these agents.
This document provides information about psychotropic drugs used in psychiatry. It discusses the definitions and classifications of psychotropic drugs including antipsychotics, antidepressants, mood stabilizers, anxiolytics, and antiepileptics. The document outlines the nurse's responsibilities regarding safe administration and monitoring of these medications and their potential side effects. It emphasizes the importance of patient education on proper use and risks of psychotropic drugs.
Hanipsych, antipsychotics and antidepressants actionHani Hamed
Antipsychotics have long been used as an adjunct treatment for depressive disorders. Only 60-70% of patients respond to antidepressants alone. Adding an antipsychotic can target multiple receptor systems and may improve outcomes. Second-generation antipsychotics are now preferred due to their safer side effect profiles. Several atypical antipsychotics have been approved to treat depressive disorders based on evidence they provide antidepressant effects. Their mechanisms of action are not fully understood but may involve influencing serotonin and dopamine pathways in areas involved in mood regulation.
The document discusses psychotropic drugs and the role of nurses in their administration. It defines psychotropic drugs as chemicals that affect the brain and nervous system, altering feelings, emotions, and consciousness. Nurses must have knowledge of pharmacokinetics, benefits and risks of psychotropic drugs, and monitor patients for side effects when administering these medications for psychiatric conditions. The document focuses on antipsychotic drugs, describing their uses, mechanisms of action, classifications, and the responsibilities of nurses in properly administering and monitoring patients receiving antipsychotic treatment.
This chapter discusses psychopharmacology and the nursing process for various drug classes. It provides background on how psychotropic drugs work and historical perspectives. For different drug classes like antidepressants, mood stabilizers, antipsychotics, and others, it outlines indications, mechanisms of action, side effects to monitor, nursing diagnoses, and important assessment factors like interactions and contraindications. The goal is to safely and effectively manage clients' medication regimens.
Antipsychotic : Dr Rahul Kunkulol's Power point preparationsRahul Kunkulol
This document discusses the treatment of psychosis and schizophrenia with a focus on antipsychotic drugs. It begins by classifying psychiatric disorders and defining psychosis. Schizophrenia is described as a particular type of psychosis characterized by disturbances in thinking. The dopamine theory of schizophrenia is explained, which posits that psychosis is related to increased dopamine activity in the brain. Older antipsychotics are dopamine antagonists that can cause neurological side effects like tardive dyskinesia. Atypical antipsychotics have fewer side effects. Lithium is discussed as the drug of choice for treating mania in bipolar disorder.
This document discusses the treatment of schizophrenia and selection of antipsychotic medications. It provides information on:
- The core symptoms of schizophrenia and their association with brain circuits and dopamine pathways.
- The evolution of antipsychotic medications from first-generation to second-generation drugs with multiple receptor mechanisms of action.
- Principles of selecting antipsychotics based on individual patient factors like efficacy, tolerability, adherence, and cost.
- Details on how different antipsychotics bind to dopamine and other receptors and the implications for symptoms, side effects, and dosing schedules.
I just wanted to share some of my Clinical Instructors lecture materials. I don't own this document, I wish to help you guys with the summary of Psychiatric Drugs.
Major depressive disorder affects around 300 million individuals worldwide and is a significant public health concern. While SSRIs are usually first-line treatment, many patients do not respond or have intolerable side effects. Novel antidepressants target multiple neurotransmitter systems and have improved efficacy and tolerability profiles. Vilazodone, vortioxetine, and levomilnacipran are newer antidepressants approved for treatment of MDD. Ketamine, psilocybin, and transcranial magnetic stimulation show promise but require more research before being widely adopted.
This document discusses pediatric psychopharmacology and provides an overview of various psychiatric disorders that affect children and the medications used to treat them. It covers the history and regulations of pediatric psychopharmacology, pharmacokinetics in children, classification of drugs, common disorders like ADHD, bipolar disorder, depression, OCD, schizophrenia, and anxiety, and summarizes evidence from studies on the effectiveness of stimulants, antidepressants, mood stabilizers, and antipsychotics in treating pediatric conditions.
Neurobiology of Substance Dependence
The document summarizes the neurobiology of substance dependence in 3 key areas:
1. Substance dependence involves changes in the brain's reward pathway including the ventral tegmental area, nucleus accumbens, and prefrontal cortex due to drug-induced alterations in neurotransmitters like dopamine.
2. Drugs of abuse activate the brain's natural reward system by increasing the release of dopamine in this pathway, initially producing feelings of pleasure but ultimately leading to maladaptive changes in brain structure and function over time.
3. Withdrawal from drugs involves dysregulation of many neurotransmitter systems producing negative symptoms that drive relapse through craving and stress. Understanding these neurobiological mechanisms provides
Disulfiram is a drug used to treat alcohol dependence by producing unpleasant reactions when alcohol is consumed while taking the drug. It works by inhibiting the breakdown of acetaldehyde, causing levels to rise over 10 times higher than normal when alcohol is ingested and resulting in symptoms like flushing, nausea, and increased heart rate. The drug is usually taken daily in tablet form to discourage drinking and support abstinence during treatment. Side effects are generally mild but can include headaches and drowsiness.
Off-Label Use of Atypical Antipsychotics: An UpdatePasquale Ariano
This document summarizes a review of the off-label use of atypical antipsychotics. It discusses how atypical antipsychotics are commonly prescribed for unapproved indications and reviews the available evidence on their effectiveness and safety when used this way. The review addressed conditions like dementia, depression, OCD, and more. It assessed outcomes like symptom severity and adverse effects. The review found the highest strength of evidence for atypical antipsychotics reducing psychosis and agitation in dementia patients compared to placebo. However, evidence was more limited for other off-label uses.
This document provides an introduction to psychopharmacology, covering general principles like drug classification, mechanisms of action, metabolism and guidelines for use. It discusses the four main drug categories - antipsychotics, mood stabilizers, antidepressants and anxiolytics - and how they are used to treat an expanding range of disorders. Key concepts covered include how drugs are absorbed, distributed, metabolized and excreted from the body. Special considerations for vulnerable patient populations and common adverse effects and their management are also summarized.
This document discusses psychotherapeutic agents used to treat mental disorders such as depression, anxiety, and psychoses. It describes different classes of antidepressants and antipsychotics, including their mechanisms of action, therapeutic uses, side effects, and nursing considerations when using these drugs. The main drug categories covered are tricyclic antidepressants, monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), and first-generation and atypical antipsychotics.
Pharmacological treatment of schizophreniajoanna1956
This document discusses the pharmacological treatment of schizophrenia. It covers the classification and clinical use of antipsychotics, the development of typical and atypical antipsychotics, their mechanisms of action and side effect profiles. It summarizes key studies on the effectiveness of typical versus atypical antipsychotics and provides recommendations from the 2009 PORT treatment guidelines for using antipsychotics to treat acute episodes and as maintenance therapy for multi-episode and first-episode schizophrenia. Alternatives to antipsychotic medication like the Soteria paradigm are also discussed.
Drug Abuse & Society (RX 462) Presentations-Spring 2014Brian Piper
This includes end of the semester presentations made by 2nd and 3rd year pharmacy students as part of an elective course. Each student was asked to provide information about history, epidemiology, pharmacodynamics, pharmacokinetics, and toxicology. Older "classic" (psilocybin, ayahuasca, crack), newer (JWB-018, mephedrone, MDA) drugs were covered as well as agents that have appreciable use outside the U.S. (desomorphine, areca nut, kava).
This document discusses the neurobiology of addiction. It explains that addiction is influenced by both genetic and environmental factors, with genes accounting for 30-60% of vulnerability. All drugs of abuse activate the brain's reward system by increasing dopamine transmission in the nucleus accumbens. Chronic drug use leads to adaptations in dopamine function and glutamatergic transmission that result in impaired reward processing, craving, and compulsive drug-seeking behaviors even after periods of abstinence. The persistence of addiction is thought to be due to long-term remodeling of synapses and circuits involved in associative memory formation and storage.
This document outlines psychotropic medications used to treat mental health conditions such as depression, bipolar disorder, and anxiety. It defines psychotropic medications as psychiatric drugs that affect brain chemistry. Common medications are discussed for each condition, along with their dosages, side effects, and nursing considerations. The document emphasizes that pregnant and breastfeeding women should discuss risks and benefits of psychotropic medication with their doctors, as limited research exists on effects during pregnancy and breastfeeding.
Quick Clinical Review of AntipsychoticsShah Parind
This document discusses antipsychotic medications, including their history, types, uses, efficacy, and side effects. It covers both typical and atypical antipsychotics, noting that atypicals are now more commonly used due to lower risk of side effects like tardive dyskinesia. Atypicals are effective for positive and negative schizophrenia symptoms as well as mood disorders but can cause metabolic issues. Proper dosing and maintenance treatment are important to prevent relapse.
In February 2013, the Office of Inspector General (OIG) released a report entitled Skilled Nursing Facilities Often Fail to Meet Care Planning Requirements, in which they found that 26% of facilities fail to meet care planning requirements. Is your facility meeting federal guidelines for care planning? This presentation discusses the important link between the MDS 3.0, the Care Area Assessments (CAAs) and the care plan. Learn the essential components of a resident-centered care plan, how to develop a care plan that supports the clinical care that is provided to the patient, and how to proactively maintain a care plan that will meet annual survey requirements. The presentation discusses strategies for completing the CAAs more effectively, and how the CAA process can be used to create a more resident-specific care plan. Learn to develop a resident centered known as ( I careplan) through a workshop discussing different elements of the careplan, from profile, interim, and diagnosis.
1. Gain an understanding of the purpose of a Care Plan.
2. Learn to define the purpose of the discharge Care Plan and Summary.
3. Learn to to articulate the link between the MDS 3.0 assessment, the nursing Care Plan, the discharge Care Plan, and accurate RUG-IV classification.
4. Understand the the correlation between the MDS 3.0 assessment, the Care Area Assessments (CAAs), and the Care Plan.
In February 2013, the Office of Inspector General (OIG) released a report entitled Skilled Nursing Facilities Often Fail to Meet Care Planning and Discharge Planning Requirements, in which they found that 26% of facilities fail to meet care planning and discharge planning requirements. Is your facility meeting federal guidelines for care planning?
Download the ABC’s of Care Planning presented by Beckie Dow, RN, RAC-MT for an overview of Care Planning in the Skilled Nursing Facility. Beckie discusses the important link between the MDS 3.0, the Care Area Assessments (CAAs) and the Care Plan.
Learn the essential components of a resident-centered care plan and how to develop a care plan that supports the clinical care that is provided to the patient. Beckie also discusses strategies for completing the CAAs more effectively and using the CAA process to create a more resident-specific care plan.
Learn How To:
1. Define the purpose of a Care Plan.
2. Define the purpose of the Discharge Care Plan and Summary.
3. Identify the correlation between the MDS 3.0 Assessment, the Care Area Assessments (CAAs), accurate RUG-IV Classification, and the Care Plan.
4. List three components of a Resident-centered Care Plan.
This document provides information about psychotropic drugs used in psychiatry. It discusses the definitions and classifications of psychotropic drugs including antipsychotics, antidepressants, mood stabilizers, anxiolytics, and antiepileptics. The document outlines the nurse's responsibilities regarding safe administration and monitoring of these medications and their potential side effects. It emphasizes the importance of patient education on proper use and risks of psychotropic drugs.
Hanipsych, antipsychotics and antidepressants actionHani Hamed
Antipsychotics have long been used as an adjunct treatment for depressive disorders. Only 60-70% of patients respond to antidepressants alone. Adding an antipsychotic can target multiple receptor systems and may improve outcomes. Second-generation antipsychotics are now preferred due to their safer side effect profiles. Several atypical antipsychotics have been approved to treat depressive disorders based on evidence they provide antidepressant effects. Their mechanisms of action are not fully understood but may involve influencing serotonin and dopamine pathways in areas involved in mood regulation.
The document discusses psychotropic drugs and the role of nurses in their administration. It defines psychotropic drugs as chemicals that affect the brain and nervous system, altering feelings, emotions, and consciousness. Nurses must have knowledge of pharmacokinetics, benefits and risks of psychotropic drugs, and monitor patients for side effects when administering these medications for psychiatric conditions. The document focuses on antipsychotic drugs, describing their uses, mechanisms of action, classifications, and the responsibilities of nurses in properly administering and monitoring patients receiving antipsychotic treatment.
This chapter discusses psychopharmacology and the nursing process for various drug classes. It provides background on how psychotropic drugs work and historical perspectives. For different drug classes like antidepressants, mood stabilizers, antipsychotics, and others, it outlines indications, mechanisms of action, side effects to monitor, nursing diagnoses, and important assessment factors like interactions and contraindications. The goal is to safely and effectively manage clients' medication regimens.
Antipsychotic : Dr Rahul Kunkulol's Power point preparationsRahul Kunkulol
This document discusses the treatment of psychosis and schizophrenia with a focus on antipsychotic drugs. It begins by classifying psychiatric disorders and defining psychosis. Schizophrenia is described as a particular type of psychosis characterized by disturbances in thinking. The dopamine theory of schizophrenia is explained, which posits that psychosis is related to increased dopamine activity in the brain. Older antipsychotics are dopamine antagonists that can cause neurological side effects like tardive dyskinesia. Atypical antipsychotics have fewer side effects. Lithium is discussed as the drug of choice for treating mania in bipolar disorder.
This document discusses the treatment of schizophrenia and selection of antipsychotic medications. It provides information on:
- The core symptoms of schizophrenia and their association with brain circuits and dopamine pathways.
- The evolution of antipsychotic medications from first-generation to second-generation drugs with multiple receptor mechanisms of action.
- Principles of selecting antipsychotics based on individual patient factors like efficacy, tolerability, adherence, and cost.
- Details on how different antipsychotics bind to dopamine and other receptors and the implications for symptoms, side effects, and dosing schedules.
I just wanted to share some of my Clinical Instructors lecture materials. I don't own this document, I wish to help you guys with the summary of Psychiatric Drugs.
Major depressive disorder affects around 300 million individuals worldwide and is a significant public health concern. While SSRIs are usually first-line treatment, many patients do not respond or have intolerable side effects. Novel antidepressants target multiple neurotransmitter systems and have improved efficacy and tolerability profiles. Vilazodone, vortioxetine, and levomilnacipran are newer antidepressants approved for treatment of MDD. Ketamine, psilocybin, and transcranial magnetic stimulation show promise but require more research before being widely adopted.
This document discusses pediatric psychopharmacology and provides an overview of various psychiatric disorders that affect children and the medications used to treat them. It covers the history and regulations of pediatric psychopharmacology, pharmacokinetics in children, classification of drugs, common disorders like ADHD, bipolar disorder, depression, OCD, schizophrenia, and anxiety, and summarizes evidence from studies on the effectiveness of stimulants, antidepressants, mood stabilizers, and antipsychotics in treating pediatric conditions.
Neurobiology of Substance Dependence
The document summarizes the neurobiology of substance dependence in 3 key areas:
1. Substance dependence involves changes in the brain's reward pathway including the ventral tegmental area, nucleus accumbens, and prefrontal cortex due to drug-induced alterations in neurotransmitters like dopamine.
2. Drugs of abuse activate the brain's natural reward system by increasing the release of dopamine in this pathway, initially producing feelings of pleasure but ultimately leading to maladaptive changes in brain structure and function over time.
3. Withdrawal from drugs involves dysregulation of many neurotransmitter systems producing negative symptoms that drive relapse through craving and stress. Understanding these neurobiological mechanisms provides
Disulfiram is a drug used to treat alcohol dependence by producing unpleasant reactions when alcohol is consumed while taking the drug. It works by inhibiting the breakdown of acetaldehyde, causing levels to rise over 10 times higher than normal when alcohol is ingested and resulting in symptoms like flushing, nausea, and increased heart rate. The drug is usually taken daily in tablet form to discourage drinking and support abstinence during treatment. Side effects are generally mild but can include headaches and drowsiness.
Off-Label Use of Atypical Antipsychotics: An UpdatePasquale Ariano
This document summarizes a review of the off-label use of atypical antipsychotics. It discusses how atypical antipsychotics are commonly prescribed for unapproved indications and reviews the available evidence on their effectiveness and safety when used this way. The review addressed conditions like dementia, depression, OCD, and more. It assessed outcomes like symptom severity and adverse effects. The review found the highest strength of evidence for atypical antipsychotics reducing psychosis and agitation in dementia patients compared to placebo. However, evidence was more limited for other off-label uses.
This document provides an introduction to psychopharmacology, covering general principles like drug classification, mechanisms of action, metabolism and guidelines for use. It discusses the four main drug categories - antipsychotics, mood stabilizers, antidepressants and anxiolytics - and how they are used to treat an expanding range of disorders. Key concepts covered include how drugs are absorbed, distributed, metabolized and excreted from the body. Special considerations for vulnerable patient populations and common adverse effects and their management are also summarized.
This document discusses psychotherapeutic agents used to treat mental disorders such as depression, anxiety, and psychoses. It describes different classes of antidepressants and antipsychotics, including their mechanisms of action, therapeutic uses, side effects, and nursing considerations when using these drugs. The main drug categories covered are tricyclic antidepressants, monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), and first-generation and atypical antipsychotics.
Pharmacological treatment of schizophreniajoanna1956
This document discusses the pharmacological treatment of schizophrenia. It covers the classification and clinical use of antipsychotics, the development of typical and atypical antipsychotics, their mechanisms of action and side effect profiles. It summarizes key studies on the effectiveness of typical versus atypical antipsychotics and provides recommendations from the 2009 PORT treatment guidelines for using antipsychotics to treat acute episodes and as maintenance therapy for multi-episode and first-episode schizophrenia. Alternatives to antipsychotic medication like the Soteria paradigm are also discussed.
Drug Abuse & Society (RX 462) Presentations-Spring 2014Brian Piper
This includes end of the semester presentations made by 2nd and 3rd year pharmacy students as part of an elective course. Each student was asked to provide information about history, epidemiology, pharmacodynamics, pharmacokinetics, and toxicology. Older "classic" (psilocybin, ayahuasca, crack), newer (JWB-018, mephedrone, MDA) drugs were covered as well as agents that have appreciable use outside the U.S. (desomorphine, areca nut, kava).
This document discusses the neurobiology of addiction. It explains that addiction is influenced by both genetic and environmental factors, with genes accounting for 30-60% of vulnerability. All drugs of abuse activate the brain's reward system by increasing dopamine transmission in the nucleus accumbens. Chronic drug use leads to adaptations in dopamine function and glutamatergic transmission that result in impaired reward processing, craving, and compulsive drug-seeking behaviors even after periods of abstinence. The persistence of addiction is thought to be due to long-term remodeling of synapses and circuits involved in associative memory formation and storage.
This document outlines psychotropic medications used to treat mental health conditions such as depression, bipolar disorder, and anxiety. It defines psychotropic medications as psychiatric drugs that affect brain chemistry. Common medications are discussed for each condition, along with their dosages, side effects, and nursing considerations. The document emphasizes that pregnant and breastfeeding women should discuss risks and benefits of psychotropic medication with their doctors, as limited research exists on effects during pregnancy and breastfeeding.
Quick Clinical Review of AntipsychoticsShah Parind
This document discusses antipsychotic medications, including their history, types, uses, efficacy, and side effects. It covers both typical and atypical antipsychotics, noting that atypicals are now more commonly used due to lower risk of side effects like tardive dyskinesia. Atypicals are effective for positive and negative schizophrenia symptoms as well as mood disorders but can cause metabolic issues. Proper dosing and maintenance treatment are important to prevent relapse.
In February 2013, the Office of Inspector General (OIG) released a report entitled Skilled Nursing Facilities Often Fail to Meet Care Planning Requirements, in which they found that 26% of facilities fail to meet care planning requirements. Is your facility meeting federal guidelines for care planning? This presentation discusses the important link between the MDS 3.0, the Care Area Assessments (CAAs) and the care plan. Learn the essential components of a resident-centered care plan, how to develop a care plan that supports the clinical care that is provided to the patient, and how to proactively maintain a care plan that will meet annual survey requirements. The presentation discusses strategies for completing the CAAs more effectively, and how the CAA process can be used to create a more resident-specific care plan. Learn to develop a resident centered known as ( I careplan) through a workshop discussing different elements of the careplan, from profile, interim, and diagnosis.
1. Gain an understanding of the purpose of a Care Plan.
2. Learn to define the purpose of the discharge Care Plan and Summary.
3. Learn to to articulate the link between the MDS 3.0 assessment, the nursing Care Plan, the discharge Care Plan, and accurate RUG-IV classification.
4. Understand the the correlation between the MDS 3.0 assessment, the Care Area Assessments (CAAs), and the Care Plan.
In February 2013, the Office of Inspector General (OIG) released a report entitled Skilled Nursing Facilities Often Fail to Meet Care Planning and Discharge Planning Requirements, in which they found that 26% of facilities fail to meet care planning and discharge planning requirements. Is your facility meeting federal guidelines for care planning?
Download the ABC’s of Care Planning presented by Beckie Dow, RN, RAC-MT for an overview of Care Planning in the Skilled Nursing Facility. Beckie discusses the important link between the MDS 3.0, the Care Area Assessments (CAAs) and the Care Plan.
Learn the essential components of a resident-centered care plan and how to develop a care plan that supports the clinical care that is provided to the patient. Beckie also discusses strategies for completing the CAAs more effectively and using the CAA process to create a more resident-specific care plan.
Learn How To:
1. Define the purpose of a Care Plan.
2. Define the purpose of the Discharge Care Plan and Summary.
3. Identify the correlation between the MDS 3.0 Assessment, the Care Area Assessments (CAAs), accurate RUG-IV Classification, and the Care Plan.
4. List three components of a Resident-centered Care Plan.
Under the scrutiny of review, rehabilitation and nursing documentation must support skilled coverage criteria. This presentation covers skilled coverage criteria and documentation by rehabilitation professionals and nursing to support clinically appropriate levels of care.
1. Learn to define skilled coverage criteria.
2. Learn to define key elements of documentation.
3. Learn examples of rehabilitation and nursing documentation to support Medicare coverage criteria.
This presentation provides a comprehensive review and forecast of the trends in Medicare Medical Review by numerous Medicare Contractors and is appropriate for all SNF Management, nursing staff, and therapy professionals. The presentation provides insight on the tidal wave of newly exposed compliance issues at the eye of the storm, leading to remote and on-site audits in the long-term care industry. Presentation highlights the historical drought in audits and the tornado effect the current scrutiny is causing amongst the SNF providers. Learn strategies to prepare records before the impending audit storm. Avoid slip ups on the seemingly invisible black ice of Medicare non-compliance. Become aware of the most recent CMS updates impacting the RAI process and subsequently reimbursement. Create an anemometer for Managers and staff to read the winds of change and create clear visibility for accurate and compliant records.
1. Learn to summarize the multiple types of Medicare Contractor Audits and associated Compliance themes.
2. Understand the trends and triggers in Compliance Audits and Common Provider Pitfalls.
3. Learn strategies for appealing Medicare Claim Denials.
This presentation provides a comprehensive pro-active review of program development for long-term care patients in the SNF. The course outlines suggestions for how rehabilitation team members can strengthen the Medicare Part B programming in the nursing facility. An overview of the Medicare Part B Guidelines, Part B Caps, Functional Limitation G-Codes, and Manual Reviews is also provided. The presentation also discusses Medicare Part B documentation, goal writing and reasons for denied claims.
1. Gain an understanding of Proactive Medicare Part B Program Development and how to strengthen the program components.
2. Gain a better understanding of Medicare Part B documentation components, goal writing and potential risk for receiving denied claims.
3. Gain an understanding of Medicare Part B Guidelines, Medicare Part B Caps, Functional Limitation G-Codes and Medical Reviews.
This document discusses missed opportunities in skilled nursing facilities related to therapy services. It identifies nurses having control over documentation as the number one missed opportunity, since nursing documentation is essential for justifying skilled care. Rehabilitation departments are identified as the number two missed opportunity, as they function as a business within the business but are often underutilized. Incomplete therapy documentation is identified as the number three missed opportunity, as it can result in denied claims and violates standards of practice. The document provides tips for improving documentation to support skilled care and medical necessity.
“Documentation not supportive of the RUG-IV classification billed…” is cited as the reason for multiple post-payment medical record review denials. Accurate and concise documentation to support the RUG-IV classification billed is a critical element in gaining accurate reimbursement, and supporting that reimbursement level during a medical review. This presentation covers the technical and clinical requirements for Medicare coverage, and requirements of skilled nursing documentation. The presentation identifies areas of the MDS 3.0 that are vulnerable to error and critical to accurate RUG-IV classification and identify strategies for better supporting these areas in medical record documentation. The correlation between the MDS 3.0 assessment and publicly reported information for the Quality Measures and 5 Star Quality Reporting are discussed.
1. Learn to describe the technical and clinical requirements for Medicare coverage.
2. Understand the goal of supportive skilled nursing documentation.
3. Develop a clear understanding of accurate coding in Section M.
4. Learn to identify sections of the MDS 3.0 assessment that are vulnerable to error and articulate strategies to support these areas in medical record documentation.
5. Learn to identify the correlation between medical record documentation, the MDS 3.0, and publicly reported information for the Quality Measures and 5 Star Quality Rating.
This document provides training on assisting clients with medication. It discusses preparing to assist with medication by establishing one's scope of practice and identifying lines of authority. It also covers preparing the client, correctly identifying each client, checking medications, recognizing when administration should not proceed, overseeing ingestion, reporting inconsistencies, completing documentation, and storing records appropriately. The goal is to provide the skills and knowledge to safely and properly assist clients with their medication needs.
The document discusses medication errors and the need for a comprehensive approach to reduce preventable errors. It reports that at least 1.5 million preventable adverse drug events occur each year in the US, costing $3.5 billion annually. The National Centers for Education and Research on Therapeutics (CERTS) were established to conduct research and provide education to optimize drug use, reduce errors and adverse events, and improve patient outcomes and health. CERTS focuses on research and web-based education for professionals and consumers around safe medication use.
Managing the medical complexities of patients with cognitive and behaviors requires an interdisciplinary approach to care. The presentation details strategies and hands-on examples of management techniques for practical application in the SNF setting to ensure patients receive medically necessary Rehabilitation and Nursing Service.
1. Learn to identify underlying deficits leading to Behaviors.
2. Learn to define interdisciplinary assessment techniques.
3. Learn Management Strategies.
Readmissions are a heightened focus under the Affordable Care Act. Initiatives are in place to reduce hospital admission through improving transition in care. During this course the speaker will discuss CMS quality initiatives, care transition, projects and barriers. This presentation reviews the key elements to tackling Avoidable Readmissions.
1. Learn to summarize the CMS quality initiative for healthcare reform related to hospital readmissions
2. Learn to identify underlying causes and barriers related to readmissions
3. Learn to state current CMS research projects and pilot programs
4. Learn to identify hospital and SNF strategies for collaboration
This document provides information about the Medicare appeals process from additional development requests (ADRs) to administrative law judge (ALJ) hearings. It includes biographies of the two speakers, Elisa Bovee and Carrie Mullin, who have extensive experience in long-term care and denials management. The document outlines the different levels of the Medicare appeals process and provides guidance on responding to ADRs and preparing appeal packages to contest claim denials.
The document discusses the importance of consumer reporting of adverse drug reactions (ADRs) in Malaysia. It notes that while Malaysia has a national pharmacovigilance program, it suffers from weaknesses like under-reporting and a lack of consumer involvement. Consumer reporting can help address under-reporting by capturing ADRs not reported by healthcare professionals. It also promotes consumer rights and participation. The document argues for establishing a consumer reporting program in Malaysia and enhancing the existing national pharmacovigilance program through improved awareness, a national drug prescription database, and strategies to improve reporting.
Preventing falls in the SNF environment can be a challenge. Learn how to become a fall CSI and inspire your interdisciplinary team to meet the challenge of Falls Reduction. Improve patient care and survey outcomes.
1. Learn to detail the Benefit of Root Cause analysis.
2. Gain an understanding of the Fall Investigation process.
3. Develop a clear understanding of accurate coding in Section M.
4. Learn how to verbalize the benefit of interdisciplinary involvement and follow-up for Fall Events.
mHealth Israel conference, UnitedHealth Group, Dr. Pramod Gaur, VP TeleHealth...Levi Shapiro
Pramod Gaur, Vice President of TeleHealth at UnitedHealth Group, presented on trends and opportunities in US telehealthcare. The presentation covered definitions of mHealth and how it can enable total population management across areas like wellness, acute/chronic care, and living with illness. Key stakeholders in the healthcare ecosystem like patients, providers, payers and regulators were discussed. The presentation also highlighted opportunities for mHealth solutions in medication management, logistics, and care support. Overall, the presentation provided an overview of the mHealth landscape and how it can help improve health outcomes and care delivery in the US healthcare system.
This document discusses the role of pharmacists in public health. It begins by outlining objectives related to identifying pharmacists' functions in public health, explaining their relevance and involvement, and listing health challenges. It then provides historical context of pharmacists' education in public health from 1932-2010. The document poses four questions to consider pharmacists' roles, including whether there is an unmet public health need pharmacists could fill. It argues pharmacists have skills to address issues like medication safety and management. Statistics on medication use and issues in the US demonstrate an unmet need pharmacists are well-suited to address.
Chapter 18 Private and Government Healthcare Systems PriMorganLudwig40
Chapter 18
Private and Government Healthcare Systems
Private and Government Healthcare Systems
In the United States, health insurance coverage is generally classified as either private (non-government) coverage or government-sponsored coverage.
Healthcare Coverage vs. Uninsured
The National Center for Health Statistics defines health insurance as public and private payers who cover medical expenditures incurred by a defined population in a variety of settings.
In the United States, the risk of becoming uninsured increases significantly for those earning low wages, the unemployed, and when employers are unable to provide insurance to workers.
Table 5-2 presents the trend of declining health insurance coverage.
Private Health Insurance
The concept of insurance is to combine the healthcare experiences of many enrollees in order to reduce expenses for any one individual to a manageable prepayment amount.
Employment-Based Plans is coverage offered through one’s own employment or a relative’s employment.
It may be offered by an employer or by a union.
Private Health Insurance Continued
Direct-Purchase/Fee-For-Service Plans are the traditional type of healthcare policy.
The physician sets a price for each type of service delivered, and then the client or insurance company pays the fee.
This type of health insurance provides the most choices of doctors and hospitals.
Private Health Insurance Continued
The two kinds of fee-for-service coverage are basic and major medical.
Basic covers some hospital services and supplies, such as X-rays and prescribed medicine.
Major medical insurance covers the cost of long-term, high-cost illnesses or injuries plus whatever basic did not cover.
Private Health Insurance Continued
Group Contract Insurance—to make hospitals and physicians products and services affordable to ordinary people in the United States.
With unmanaged care (fee-for-service) payments, healthcare providers could increase the number of single services they deliver in order to increase profit.
Private Health Insurance Continued
Managed Care—manages the cost and delivery of healthcare services, the quality of that healthcare, and access to care.
Managed care influences how much healthcare clients can use.
Health Maintenance Organizations (HMOs) are prepaid health plans.
The goal of an HMO is to provide affordable, well-organized healthcare by allowing clients to prepay (capitation payment) on a regular monthly basis for all services provided.
Private Health Insurance Continued
Including physicians’ visits, hospital stays emergency care, surgery, laboratory (lab) tests, X-rays, and therapy for all members and their families.
There may be a small co-payment for each office visit, such as $15 for a doctor’s visit or $50 for hospital emergency room treatment.
Private Health Insurance Continued
Point-of-Service Plans (POS) offer enrollees the option of receiving services from participating or nonparticipating prov ...
Key Stakeholders in Public Health Issue.docx4934bk
Key stakeholders in a public health issue include those affected by the issue as well as those who can influence or make decisions related to the issue. It is important to identify stakeholders to understand their interests and perspectives which informs policy analysis. Primary care physicians, specialists, and other healthcare providers have an interest in public health issues that impact patient care. Government agencies also have an interest as they are responsible for funding programs and creating regulations and policies. Identifying stakeholders is crucial for conducting a thorough policy analysis.
Can your Skilled Nursing Facility (SNF) afford to provide care to Medicare patients and not receive accurate and appropriate reimbursement? The resources utilized to respond to additional documentation requests, manage denials and the loss of revenue for care provided can have a devastating impact on your facilities budget. In addition, early identification of potential issues and prompt resolution of actual issues reduces a facilities risk of hefty fines and penalties related to non-compliance.
Skilled Nursing Facilities are required to have a compliance program effective March 2013. Compliance programs strengthen and document a SNFs efforts to prevent and reduce Medicare fraud and abuse and ensure accurate and appropriate reimbursement for quality care provided. Under SNF compliance regulations Medicare has redefined the definition of fraud. When a facility has not taken all the necessary steps to ensure all the technical and clinical qualifications are supported by your medical records to prevent improper billing, fines and penalties may be applied. The critical components of an effective compliance program include monitoring and auditing to ensure Skilled Nursing Facility provider's have a formalized and proactive approach towards detecting fraud, abuse, and waste of precious company resources.
Similar to Is Antipsychotic Medication Reduction Making You Crazy? (20)
On July 31, 2014, the Centers for Medicare and Medicaid Services (CMS) issued the Final Rule under the Medicare Program: Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities to be implemented on October 1, 2014. This seminar will discuss the impact of Fiscal Year 2015 Medicare payment rate increases for Skilled Nursing Facilities (SNFs) and will review the most recent Office of Management and Budget (OMB) statistical area delineations affecting the SNF PPS Wage Index. Learn about the revision to the existing COT OMRA policy. Additionally attendees will be apprised of updates to Chapter 8, Section 30 of the Medicare Benefit Policy Manual (Pub. 100-02) which directs providers on coverage decisions for reasonable and necessary treatment of patient’s illness or injury.
Skilled Nursing Facilities have seen a significant increase in Medicare Part A and Part B Therapy denials. The goal of medical review is to determine whether the services are reasonable and necessary, delivered in the appropriate setting, and coded correctly, based on appropriate documentation. The speaker will begin this seminar by discussing recent national trends in Medical Review, reasons for increased review and the various Medical Review programs. The speaker will present specific denial trends associated with Medicare Part B Claims. The presentation will culminate in a review of the keys to responding to a medical record request and appeal tips and strategies.
This document discusses strategies for appealing denied Medicare claims. It begins with an introduction to the presenter, Carrie Mullin, and her experience reviewing denied claims. The objectives are then outlined as understanding Medicare medical review goals, identifying documentation to support skilled care, and strategies for appeals. The document goes on to list common denial reasons from Medicare and provides suggestions for additional documentation to address potential denial issues in an appeal. It emphasizes understanding Medicare guidelines and policies to effectively argue that skilled services were necessary.
The Skilled Nursing Facility (SNF) “Program for Evaluating Payment Patterns Electronic Report” (PEPPER) was released in April 2014 by CMS. Join Keri Hart, MS, CCC-SLP, CHHRP-QT, RAC-CT, in this in-depth interpretation of the elements of the PEPPER. Keri will detail how to interpret your PEPPER and discuss the practical application of this critical information to your Skilled Nursing Facility’s practice. Follow along with your own PEPPER report to develop an action plan to ensure compliance with Medicare regulatory requirements and ensure accurate reimbursement for clinically appropriate care provided.
CMS introduced this new annual report for Skilled Nursing Facilities in August 2013. PEPPER data is shared with both Medicare Administrative Contractors (MACs) and the Medicare Recovery Audit Contractors (RACs). This important report details your facility-specific Medicare claims data in certain targeted areas and compares your facility to other SNFs Nationally, by State and by Jurisdiction (Medicare Administrative Contractors/Fiscal Intermediaries).
The Skilled Nursing Facility (SNF) “Program for Evaluating Payment Patterns Electronic Report” (PEPPER) was released in April 2014 by CMS. CMS introduced this new annual report for Skilled Nursing Facilities in August 2013. PEPPER data is shared with both Medicare Administrative Contractors (MACs) and the Medicare Recovery Audit Contractors (RACs). This important report details your facility-specific Medicare claims data in certain targeted areas and compares your facility to other SNFs Nationally, by State and by Jurisdiction (Medicare Administrative Contractors/Fiscal Intermediaries).
The goal of medical review is to determine whether the services are reasonable and necessary, delivered in the appropriate setting, and coded correctly, based on appropriate documentation. The speaker will begin this seminar by discussing the goals of Medical Review and various Medical Review programs including Recovery Audit Contractor (RAC) and Carrier (Medicare Administrative Contractor or Fiscal Intermediary) Medical Review programs.
As digitization of the healthcare industry increases, the need to safeguard electronic patient data is also becoming increasingly important. Electronic protected health information (ePHI) is not just in the electronic medical records (EMRs). It also resides in emails, in documents and images on computers, servers, printer hard drives and mobile devices like laptops, cell phones, tablets and USB memory sticks. Healthcare professionals are also using texting and online file sharing services to conveniently share confidential information. The loss of this confidential patient health information is disastrous for patients and healthcare organizations.
Survey preparation is a never ending process and with the new QIS survey process in transition, it represents a new paradigm shift. This presentation will provide insight into key elements, tips and strategies that providers should use as part of their quality assurance survey preparation efforts. Learn from this multi-level licensed nursing home administrator with expertise in regulatory compliance sharing his lessons learned through the years.
This document summarizes a presentation about healthcare compliance for skilled nursing facilities (SNFs). It discusses the impact of Office of Inspector General (OIG) audits finding high rates of billing errors in SNF Medicare claims. It reviews the Program for Evaluating Payment Patterns Electronic Report (PEPPER), which analyzes SNF claims data to identify outlier facilities. It emphasizes the importance of SNFs developing compliance programs to regularly audit claims and ensure appropriate billing. It also notes increased government scrutiny of healthcare fraud and changes to false claims acts that expand liability for incorrect billing.
Improve participation and functional outcomes through creativity out of the gym. Functionally based treatment will ensure patients receive medically necessary physical therapy, occupational therapy and speech services. The presentation reviews practical application to Medicare requirements.
1. Learn to identify creative treatment strategies.
2. Learn to define Medicare coverage and Medicare documentation.
3. Learn to identify the clinical benefits of Functional Based Therapies.
A comprehensive review of the Medicare appeal process. Appropriate for all SNF nursing staff, management, and therapy professionals. The presentation discusses the level of Medicare appeal, how facilities can thoroughly and timely manage the appeal process, and how facilities can participate in a successful ALJ hearing.
This document provides an overview and agenda for a presentation on successfully preventing and appealing denied Medicare claims. The presentation will cover audit triggers, contractor findings, medical record review preparedness, appeal tools, and strategies for successful appeals. It will discuss the admission documentation requirements, skilled care qualifications, and appeal processes to facilitate preventing and appealing denied claims.
Provisions set forth in the Affordable Care Act (ACA) require the Centers for Medicare and Medicaid Services (CMS) to broaden quality improvement activities in nursing homes. Although the mandatory implementation date for nursing homes to provide evidence of a systematic Quality Assurance and Performance Improvement (QAPI) program has been delayed, but facilities should not delay in implementing a detailed and well-documented QAPI program. This presentation moves beyond the five elements of a QAPI and begins to drill down to practical concepts for “beefing up” an existing Quality Improvement program to meet QAPI standards. Learn how to objectively assess where your facility is in the QAPI journey, and gain a deeper insight into how practical implementation of QAPI activities can be a part of the culture of excellence that is part of all successful nursing homes.
1. Learn to detail the five elements of QAPI and correlate the five elements to the twelve step action plan for QAPI implementation.
2. Learn to articulate the steps to evaluating their facilities progress in QAPI efforts.
3. Understand Performance Improvement Projects (PIPs).
4. Learn the five steps of Root Cause Analysis (RCA) and learn how to apply the RCA process to adverse events in their facility routinely.
This New York Medicaid Nursing Facility Case Mix Seminar discusses the necessary documentation needed to support the assigned Medicaid RUG to ensure accurate reimbursement for care provided. New York OMIG Auditors are focused on auditing "high risk" Medicaid Case Mix MDSs for Nursing Facilities with a change in CMI by more than five percent for 2012.
1. Learn to identify the specific components of NY RUG-III 53 categories.
2. Learn to identify high risk NY RUG-III 53 categories.
3. Learn to identify documentation requirements to support the RUG components.
4. Learn to identify strategies for organization of the Medical Record in preparation for OMIG Audits.
The management of the Minimum Data Set (MDS) 3.0 assessment schedule is complex and time consuming. Combining scheduled MDS assessments with unscheduled Prospective Payment System (PPS) Other Medicare Required Assessments (OMRAs) correctly will lead to accurate reimbursement and can ease the MDS workflow burden on the entire team, and save the facility costly mistakes due to noncompliance. Practitioners need to know what to do if the MDS schedule is not followed correctly, and how to regain compliance with the schedule as quickly as possible. This presentation reviews the scheduled and unscheduled PPS assessment requirements and describe how to select and set Assessment Reference Dates (ARDs) strategically and accurately. The presentation also discusses implications of not following the assessment schedule correctly, and how to regain compliance once an error in assessment scheduling is discovered. The Correction Process of existing MDS assessments, including modification, inactivation, and manual correction request will be discussed. This all-important information will help the MDS coordinator to maintain and regain federal compliance with the PPS assessment schedule.
1. Learn to outline the scheduled PPS assessment schedule and unscheduled PPS assessment requirements and explain the correct Assessment Reference Date selection for each assessment type.
2. Learn to state the correct application of default or provider liable days for an early, late, or missed scheduled or unscheduled assessment.
3. Learn to identify the appropriate use of the Start of Therapy OMRA, End of Therapy OMRA, End of Therapy-Resumption OMRA, and Change of Therapy OMRA.
4. Learn the eight criteria for a Medicare Short-Stay assessment.
5. Learn to identify the difference between a MDS modification and a MDS inactivation and recognize when to choose modification or inactivation.
The presentation details the value of standardized therapy assessment as it relates to patient care treatment planning and evidencing Medicare audits. Standardized assessments can help evidence your patients’ progress. In addition, standardized assessment can better define deficits and assist in treatment planning.
1. Learn to identify the Benefits of utilizing Standardized assessments
2. Learn to summarize appropriate use of standardized therapy assessments
3. Learn the reasons standardized assessments can be used to evidence progress and support Medicare Part G-codes
One of the major goals in MDS 3.0 is to give residents and families a more active voice in the care delivered. Interviewing processes are provided in the MDS 3.0 RAI user’s manual to help caregivers obtain quality, accurate information from patients with focused scripted interview questions. This presentation discusses techniques for interviewing that will assist with achieving more accurate data for physical therapy care and MDS coding. The presentation reviews key sections of the MDS that are coded based on direct patient interviews.
1. Learn to identify the MDS Sections which are coded based on scripted resident interview.
2. Learn to describe three specific techniques that can be used to achieve accurate interview results.
3. Gain an understanding of key RUG reimbursement and quality measure impacts of the resident interviews.
4. Learn to summarize strategies for utilization of resident interview data to drive quality of care and improve quality of life in the SNF.
The MDS 3.0 has an impact on every aspect of care in a LTC or SNF. Reimbursement, Quality Measures, Five Star rating, Care Planning, and resident-centered care all begin with an accurate, standardized, and reproducible assessment.
Download the MDS 3.0: A Guide To Coding Accuracy by Beckie Dow, RN, RAC-MT for an overview of MDS 3.0. Beckie reviews the MDS 3.0 sections most vulnerable to error, while highlighting strategies for increased accuracy. Beckie also provides the MDS scheduling clinical qualifiers for each of the 66 RUG-IV categories and examples of potential financial losses due to inaccurate coding.
Learn How To:
1. Identify three MDS 3.0 Sections vulnerable to error.
2. Identify strategies for accurate reimbursement through the MDS 3.0 process.
3. Articulate three recent MDS 3.0 Coding instruction updates.
Keep your MDS Coordinators and nursing staff up to speed in understanding the significance of accurate coding in section M and the required corresponding documentation. This presentation enables healthcare providers to provide quality healthcare through an understanding of wound coding in relationship to skin presentation for Section M on the MDS assessment.
1. Gain an understanding of the RAI User’s Manual intent of Section M.
2. Gain an understanding of the documentation required to support Coding in Section M.
3. Develop a clear understanding of accurate coding in Section M.
4. Learn to identify the significance of care planning and utilizing an interdisciplinary approach.
Managing the medical complexities of patients with cognitive and behaviors requires an interdisciplinary approach to care. The presentation details strategies and hands-on examples of management techniques for practical application in the SNF setting to ensure patients receive medically necessary Rehabilitation and Nursing Service.
More from Harmony Healthcare International (HHI) (20)
Feeding plate for a newborn with Cleft Palate.pptxSatvikaPrasad
A feeding plate is a prosthetic device used for newborns with a cleft palate to assist in feeding and improve nutrition intake. From a prosthodontic perspective, this plate acts as a barrier between the oral and nasal cavities, facilitating effective sucking and swallowing by providing a more normal anatomical structure. It helps to prevent milk from entering the nasal passage, thereby reducing the risk of aspiration and enhancing the infant's ability to feed efficiently. The feeding plate also aids in the development of the oral muscles and can contribute to better growth and weight gain. Its custom fabrication and proper fitting by a prosthodontist are crucial for ensuring comfort and functionality, as well as for minimizing potential complications. Early intervention with a feeding plate can significantly improve the quality of life for both the infant and the parents.
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)bkling
Your mindset is the way you make sense of the world around you. This lens influences the way you think, the way you feel, and how you might behave in certain situations. Let's talk about mindset myths that can get us into trouble and ways to cultivate a mindset to support your cancer survivorship in authentic ways. Let’s Talk About It!
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
At Apollo Hospital, Lucknow, U.P., we provide specialized care for children experiencing dehydration and other symptoms. We also offer NICU & PICU Ambulance Facility Services. Consult our expert today for the best pediatric emergency care.
For More Details:
Map: https://cutt.ly/BwCeflYo
Name: Apollo Hospital
Address: Singar Nagar, LDA Colony, Lucknow, Uttar Pradesh 226012
Phone: 08429021957
Opening Hours: 24X7
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...rightmanforbloodline
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...nirahealhty
The South Beach Coffee Java Diet is a variation of the popular South Beach Diet, which was developed by cardiologist Dr. Arthur Agatston. The original South Beach Diet focuses on consuming lean proteins, healthy fats, and low-glycemic index carbohydrates. The South Beach Coffee Java Diet adds the element of coffee, specifically caffeine, to enhance weight loss and improve energy levels.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareDr. David Greene Arizona
Explore the groundbreaking work of Dr. David Greene, a pioneer in regenerative medicine, who is revolutionizing the field of cardiology through stem cell therapy in Arizona. This ppt delves into how Dr. Greene's innovative approach is providing non-surgical, effective treatments for heart disease, using the body's own cells to repair heart damage and improve patient outcomes. Learn about the science behind stem cell therapy, its benefits over traditional cardiac surgeries, and the promising future it holds for modern medicine. Join us as we uncover how Dr. Greene's commitment to stem cell research and therapy is setting new standards in healthcare and offering new hope to cardiac patients.
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
Is Antipsychotic Medication Reduction Making You Crazy?
1. Is Antipsychotic Medication
Reduction Making You Crazy?
HARMONY UNIVERSITY
The Provider Unit of
Harmony Healthcare International, Inc. (HHI)
Presented by:
Kim Steele RN, WCC, RAC-CT, CHHRP
Regional Consultant and Trainer